Pharmaceutical economics on the role of drug cost control.docVIP

 PAGE \* MERGEFORMAT 9 Pharmaceutical economics on the role of drug cost control Keywords:] drugs economics, medicine, public health In recent years, China’s national health care costs at an annual growth rate of 30%, far outstripping the 10% GDP growth rate, which seriously affected China’s economic development and people’s living standards. How to control Yiliao The rapid growth in costs has become a concern and we need to address the problem. Drug cost is an important part of medical expenses, medical expenses in the whole occupies a large proportion, especially in Western medicine is the rapid growth of medical costs led to a major factor One of the Chinese medicine is relatively low. At present, the hospital’s business is about 50% of revenue comes from drugs, which control the focus of medical costs is to control the rapid growth of drug costs. 1 drug cost growth and solution Control the rapid growth of drug costs is to figure out the key causes of the rising cost of drugs, and prescribe the right medicine. Rapid growth in drug costs caused by many factors, but summed up in one of two aspects: First, rational factors, that is not controllable factors. Such as population growth and aging, disease changes, chronic diseases increased, the residents increased health awareness, drug costs improvement, etc; the second is irrational factors. loopholes, such as price management, hospital compensation mechanisms are inadequate to drugs to support medical, medication management slack, improper use and over-reliance on Western medicine and other patients. Control drug costs from the providers of medical services (hospitals), pay and demand side (patients) and other aspects, the focus was as much as possible to meet the medical needs of the people control the rising costs on the basis of some irrational factors core is a reasonable use of limited health resources, health services to ensure equity and special needs of the. Currently, control of drug